Accredited Continuing Medical Education and the FDA's Risk Evaluation and Mitigation Strategies: A Fact Sheet for Accredited CME Providers

Publish Date: 
Tuesday, August 27, 2013

This fact sheet for accredited providers within the ACCME system answers questions about the FDA Extended-Release and Long-Acting Opioid Analgesics REMS and explains the role of accredited continuing education, the ACCME, and accredited providers in addressing prescription drug safety and fulfilling the goals of the REMS. It describes how the ACCME is participating in the REMS data collection and auditing process as a service to the CME community and to the FDA.  At the end of the fact sheet is a resource that describes the ACCME's understanding of the shared responsibilities of the RPC, ACCME, and accredited providers.